Christine C Alewine

13PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersSeparation technologiesCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 15, 2026
Basal Marker ΔNp63α Is Enriched in Pancreatic Cancer Metastases but Not in Primary Tumors Post-Chemotherapy.

|Dec 15, 2025
Controlled Self-Immolative Release of β-Lapachone via an Optimized para-Hydroxybenzyl Linker for Targeted Pancreatic Cancer Therapy.

Julie B Becher, Nisita Dutta, Claudio D Navo

|Dec 14, 2024
Excess shed mesothelin disrupts pancreatic cancer cell clustering to impair peritoneal colonization.

Theressa Ewa, Neel Panchwagh, Chin-Hsien Tai

|Feb 15, 2024
Macrophages Under the Influence of Tumor Mesothelin Weaken Host Defenses against Pancreatic Cancer Metastasis.

Christine Alewine

|Oct 08, 2022
Systemic immune changes accompany combination treatment with immunotoxin LMB-100 and nab-paclitaxel.

Guillaume Joe Pegna, Min-Jung Lee, Cody J Peer

|Sep 09, 2022
Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma.

Nebojsa Skorupan, Mayrel Palestino Dominguez, Samuel L Ricci

Pageof 3

Frequent Collaborators

2 joint publications

Chin-Hsien Tai

2 joint publications

Leela Rani Avula

2 joint publications

Jian Xu

1 joint publications

Rakan Albalawy